跳至主要内容
临床试验/NCT00701831
NCT00701831已完成4 期

Assessment of Forced Titration to Reach the Effective Dose for Good Glycemic Control in Lantus Treated Type 2 Patients

Sanofi1 个研究点 分布在 1 个国家目标入组 241 人开始时间: 2008年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Sanofi
入组人数
241
试验地点
1
主要终点
HbA1c, FBG

研究概览

简要总结

Primary objective:

  • To observe the efficacy of the forced titration to reach good glycemic control in Lantus treated patients

Secondary objectives:

  • To assess the forced titration on physician and patient satisfaction
  • To evaluate the impact of training tools by means of patient profile

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • T2 insulin naïve patients
  • Patients whom their physician is considering initiation of Lantus treatment
  • Poor glycemic control 7,5 %10 %
  • T2 treatment with OADs more than 3 months
  • BMI<40 kg/m2

排除标准

  • Impaired renal function (Cr>2mg/dl or current renal dialysis)
  • Acute or chronic metabolic acidosis
  • Active liver disease or serum ALT or AST >2,5 than normal
  • History of hypoglycemia unawareness
  • Diabetic retinopathy with surgery in the previous 3 months or planned within 3 months after study entry
  • Pregnancy, breast feeding
  • The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

研究组 & 干预措施

1

Experimental

Insulin glargine

干预措施: Insulin glargine (Drug)

结局指标

主要结局

HbA1c, FBG

时间窗: after treatment end (6 months)

Final dose

时间窗: after treatment end (6 months)

Number of dose adjustment

时间窗: after treatment end (6 months)

Time to dose titration

时间窗: after treatment end (6 months)

次要结局

  • Hypoglycemia(after treatment end (6 months))
  • Noctural hypoglycemia(after treatment end (6 months))
  • DTSQ(after treatment end (6 months))
  • Physician Satisfaction Questionnaire(after treatment end (6 months))

研究者

发起方
Sanofi
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验